The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Demina O.M.

FUV GBOU VPO RNIMU im. N.I. Pirogova Minzdrava Rossii, Moskva

Time course of changes in the indicators of phagocytosis and cell growth factors in patients with acne vulgaris during

Authors:

Demina O.M.

More about the authors

Read: 1560 times


To cite this article:

Demina OM. Time course of changes in the indicators of phagocytosis and cell growth factors in patients with acne vulgaris during. Russian Journal of Clinical Dermatology and Venereology. 2013;11(3):23‑29. (In Russ.)

Recommended articles:
Expe­rience of comprehensive treatment of erythematotelangiectatic rosa­cea. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):236-239
Modern aspe­cts of photo and laser therapy for wound infe­ction in surgical practice. Piro­gov Russian Journal of Surgery. 2024;(12-2):134-138

References:

  1. Potekaev N.N. Akne i rozatsea. M 2007; 216.
  2. Anfimova N.A. Patogeneticheskoe obosnovanie fotodinamicheskoi terapii v kompleksnom lechenii vul'garnykh ugrei: Avtoref. dis. … kand. med. nauk. M 2005; 135.
  3. Berlien Kh.-P., Myuller G.I. Prikladnaya lazernaya meditsina. Per. s nem. M: AO Interekspert 1997; 356.
  4. Brill' G.E., Gasparyan L.V. Adaptogennye effekty nizkointensivnogo lazernogo izlucheniya. Materialy nauchno-prakticheskoi konferentsii "Sovremennye dostizheniya lazernoi meditsiny i ikh primenenie v prakticheskom zdravookhranenii". M 2006; 166.
  5. Vorob'ev A.A., Bykov A.S., Karaulov A.V. Immunologiya i allergologiya. M 2006; 288.
  6. Ketlinskii S.A., Simbirtsev A.S. Tsitokiny. SPb 2008; 552.
  7. Meil D. Immunologiya. Per. s angl. M 2007; 568.
  8. Kubanova A.A., Kisina V.I. Ratsional'naya farmakoterapiya zabolevanii kozhi i infektsii, peredavaemykh polovym putem. M 2005; 882.
  9. Fedotov V.P., Svyatenko T.V. Akne: teoriya i praktika. Dermatovenerol kosmetol i seksopatol 2006; 1-2: 9: 80-85.
  10. Tsyb A.F., Kaplan M.A. Vozmozhnosti i perspektivy primeneniya fotodinamicheskoi terapii (eksperimental'nye i klinicheskie issledovaniya). Ros med vestn 2002; 3: 19-24.
  11. Abd E., Shoukry N., El Maged R., Avada M. Immunohistochemical expression of interleukin 8 in skin biopsies from patients with inflammatory acnes vulgaris. Diagn Pathol 2007; 30: 2-4.
  12. Fenner J.A., Wiss K., Levin N.A. Oral cephalexin for acne vulgaris: clinical experience with 93 patients. Pediatr Dermatol 2008; 25: 2: 179-183.
  13. Gold M. Acne and PDT: new techniques with lasers and light sources. Laser Med Sci 2007; 22: 2: 67-72.
  14. Haedersdal M., Togsverd-Bo K., Wulf H.C. Evidence-based review of lasers, light sources and photodynamic therapy in the treatment of acne vulgaris. J Eur Acad Dermatol Venerol 2008; 22: 3: 267-278.
  15. Juzeniene A., Moan J. The history of PDT in Norway. Part one: Identification of basic mechanisms of general PDT. Photodiagn Photodyn Ther 2007; 4: 1: 3-11.
  16. Katsambas A., Dessinoti C. New and emerging treatments in dermatology: acne. Dermatol Ther 2008; 21: 2: 86-95.
  17. Kim J. Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. Dermatol 2005; 211: 3: 193-198.
  18. Nagy I., Pivarcsi A., Kis K., Koreck A., Bodai L., McDowell A., Seltmann H., Patrick S., Zouboulis C.C., Kemény L. Propionbacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microbes Infect 2006; 8: 8: 2195-2205.
  19. Nakatsuji T., Liu Y.T., Huang C.P., Zoubouis C.C., Gallo R.L., Huang C.M. Antibodies Elicited by Inactivated Propionibacterium acnes-based vaccines exert protective immunity and attenuate the IL-8 production in human sebocytes: relevance to therapy for Acne Vulgaris. J Invest Dermatol 2008; 128: 10: 2451-2457.
  20. Decker A., Graber E.M. Over-the-counter acne treatments: a review. J Clin Aesthet Dermatol 2012; 5: 5: 32-40.
  21. Pivarcsi A., Bodai L., Rethi B., Kenderessy-Szabó A., Koreck A., Széll M., Beer Z., Bata-Csörgoo Z., Magócsi M., Rajnavölgyi E., Dobozy A., Kemény L. Expression and function of toll-like receptors 2 and 4 human keratinocytes. Int Immunol 2003; 15: 6: 721-730.
  22. Wilcox H.E., Farrar M.D., Cunliffe W.J., Holland D.B., Ingham E. Resolution of inflammatory acne vulgaris may involve regulation of CD4+ T-cell responses to Propionibacterium acnes. Br J Dermatol 2007; 156: 3: 460-465.
  23. Yung A., Stables G.L., Fernandez C., Williams J., Bojar R.A., Goulden V. Microbiological effect of photodynamic therapy (PDT) in healthy volunteers: a comparative study using methyl aminolaevulinate and hexyl aminolaevulinate cream. Clin Exp Dermatol 2007; 32: 6: 716-721.
  24. Orringer J., Kang S., Maier L., Jonson T., Sachs D.L., Karimipour D.J., Helfrich Y.R., Hamilton T., Voorhees J.J. A randomized, controlled, split-face clinical trial of 1320-nm Nd:YAG laser therapy in treatment of acne vulgaris. J Am Acad Dermatol 2007; 56: 3: 432-438.
  25. Seaton E.D., Mouser P., Charakida A., Alam S., Seldon P., Chu A. Investigation of the mechanism of action of nonablative pulsed-dye laser therapy in photorejuvenation and inflammatory acnes vulgaris. Br J Dermatol 2006; 155: 4: 748-755.
  26. Gold M.H., Rao J., Goldman M.P., Bridges T.M., Bradshaw V.L., Boring M.M., Guider A.N. A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution. J Drugs Dermatol 2005; 4: 1: 64-70.
  27. Wheeland R.G., Koreck A. Safety and Effectiveness of a New Blue Light Device for the Self-treatment of Mild-to-moderate Acne. J Clin Aesthet Dermatol 2012; 5: 5: 25-31.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.